143 related articles for article (PubMed ID: 2496557)
21. Leukemic cells from a chronic T-lymphocytic leukemia patient proliferated in response to both interleukin-2 and interleukin-4 without prior stimulation and produced interleukin-2 mRNA with stimulation.
Umadome H; Uchiyama T; Onishi R; Hori T; Uchino H; Nesumi N
Blood; 1988 Oct; 72(4):1177-81. PubMed ID: 3262382
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
[TBL] [Abstract][Full Text] [Related]
23. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation.
Perri RT; Kay NE
Am J Hematol; 1989 Jul; 31(3):166-72. PubMed ID: 2500849
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
25. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
26. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.
Fluckiger AC; Garrone P; Durand I; Galizzi JP; Banchereau J
J Exp Med; 1993 Nov; 178(5):1473-81. PubMed ID: 8228801
[TBL] [Abstract][Full Text] [Related]
28. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
Perri RT
Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
[TBL] [Abstract][Full Text] [Related]
29. Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.
Karasuyama H; Rolink A; Melchers F
J Exp Med; 1988 Apr; 167(4):1377-90. PubMed ID: 3128631
[TBL] [Abstract][Full Text] [Related]
30. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.
Jahrsdörfer B; Blackwell SE; Wooldridge JE; Huang J; Andreski MW; Jacobus LS; Taylor CM; Weiner GJ
Blood; 2006 Oct; 108(8):2712-9. PubMed ID: 16809616
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
[TBL] [Abstract][Full Text] [Related]
32. B-cell chronic lymphocytic leukaemia populations respond stochastically to combinations of growth signals in vitro.
McManus AP; Desai ZR; Lavabre-Bertrand T
Leuk Res; 1993 Jun; 17(6):477-81. PubMed ID: 8505846
[TBL] [Abstract][Full Text] [Related]
33. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S
Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201
[TBL] [Abstract][Full Text] [Related]
34. Does IL-2 receptor expression and secretion in chronic B-cell leukemia have a role in down-regulation of the immune system?
Burton J; Kay NE
Leukemia; 1994 Jan; 8(1):92-6. PubMed ID: 8289505
[TBL] [Abstract][Full Text] [Related]
35. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
36. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
[TBL] [Abstract][Full Text] [Related]
37. The p24 leucocyte membrane antigen: modulation associated with lymphocyte activation and differentiation.
Zola H; Furness V; Barclay S; Zowtyj H; Smith M; Melo JV; Neoh SH; Bradley J
Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():63-70. PubMed ID: 2785956
[TBL] [Abstract][Full Text] [Related]
38. Chronic lymphocytic leukemia cells induce non-T cells to produce IgE in the presence of interleukin-4.
Nüsslein HG; Dietz A; Burger R; Träg T; Kalden JR; Gramatzki M
J Clin Immunol; 1993 Nov; 13(6):397-405. PubMed ID: 8288724
[TBL] [Abstract][Full Text] [Related]
39. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.
Rossi JF; Commes T; Grenier J; Jourdan M; Chichehian B; Klein B
Am J Hematol; 1988 Dec; 29(4):183-8. PubMed ID: 3142255
[TBL] [Abstract][Full Text] [Related]
40. C3b receptors mediate the growth factor-induced proliferation of malignant B-chronic lymphocytic leukemia lymphocytes.
Caligaris-Cappio F; Schena M; Bergui L; Tesio L; Riva M; Rege-Cambrin G; Funaro A; Malavasi F
Leukemia; 1987 Nov; 1(11):746-52. PubMed ID: 2960860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
